Health & Fitness
Health and Fitness
Health and Fitness
Thu, July 22, 2010
Wed, July 21, 2010
Tue, July 20, 2010 Incyte to Report Second Quarter 2010 Financial Results and Provide Update on Drug Discovery & Development Programs on August 5
WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its second quarter 2010 financial results conference call for 8:30 a.m. ET on Thursday, August 5, 2010. The schedules for the press release and conference call are as follows:
| -- Q2 2010 Press Release: | August 5, 2010 at 7:00 a.m. ET | |||||
| -- Q2 2010 Conference Call: | August 5, 2010 at 8:30 a.m. ET | |||||
| -- Domestic Dial In Number: | 877-269-7756 | |||||
| -- International Dial In Number: | 201-689-7817 | |||||
| -- Conference ID # | 354043 |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 354043.
The conference call will also be webcast live on CCBN and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. Incytea™s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].
